Turkey Tail Mushroom
Trametes versicolor
One of the most studied functional mushrooms for canine immune support
Turkey Tail (Trametes versicolor) is a bracket fungus named for its colorful fan-shaped fruiting bodies. It is one of the most extensively studied functional mushrooms, containing polysaccharide-K (PSK) and polysaccharide-P (PSP) — complex polysaccharides with well-documented immune-modulating properties.
Turkey Tail is used in DOG-1 for its beta-glucan content and the available evidence supporting its role in immune modulation. It is the functional mushroom with the most canine-specific research, including a notable study from the University of Pennsylvania.
Turkey Tail's PSK and PSP polysaccharides interact with pattern recognition receptors on immune cells, stimulating macrophage activity, natural killer cell function, and cytokine production. These interactions support the body's immune surveillance and response systems.
- ✓Immune Function
- ✓Antioxidant Defense
- ✓Cellular Health
What Is Turkey Tail?
Trametes versicolor, commonly known as Turkey Tail, is one of the most common bracket fungi in North American and European forests. Its colorful, fan-shaped fruiting bodies with concentric rings of brown, tan, and white resemble a turkey's tail feathers, giving it its common name.
Turkey Tail has been used in traditional Chinese medicine for centuries and has been the subject of extensive modern scientific research, particularly in Japan where PSK (a proprietary Turkey Tail extract) has been used as an adjunct cancer therapy for decades.
Key Bioactive Compounds
Turkey Tail contains two primary polysaccharide complexes that have been most extensively studied: PSK (polysaccharide-K, also called krestin) and PSP (polysaccharide-P). Both are beta-glucan-protein complexes with immune-modulating properties. Turkey Tail also contains a range of other polyphenols and antioxidant compounds.
PSK has been used as an approved pharmaceutical agent in Japan since the 1980s, where it is prescribed as an adjunct to conventional cancer treatment. This extensive clinical use has generated a substantial body of human research on its safety and efficacy.
The Canine Study
The most notable canine research on Turkey Tail was conducted at the University of Pennsylvania School of Veterinary Medicine by Dr. Dorothy Cimino Brown and Dr. Jennifer Reetz. This study examined the effects of Turkey Tail polysaccharopeptide (PSP) in dogs with hemangiosarcoma — an aggressive cancer of blood vessel cells that is common in dogs.
The study found that dogs receiving Turkey Tail PSP had significantly longer median survival times compared to historical controls. Dogs receiving the highest dose (100 mg/kg) had a median survival of 199 days, compared to 86 days in historical controls. While this research is promising, it is important to note that it involved dogs with a specific cancer diagnosis, not healthy dogs, and should not be interpreted as evidence that Turkey Tail prevents cancer in healthy animals.
Important Limitations
The canine hemangiosarcoma study, while significant, involved dogs with cancer rather than healthy dogs. Most other research on Turkey Tail has been conducted in humans or laboratory animals. The mechanisms by which Turkey Tail supports immune function in healthy dogs are not as well characterized as its effects in disease states. Product quality varies — the beta-glucan content and bioavailability of Turkey Tail products depends on the species used, growing conditions, and extraction method.
Turkey Tail is one of three functional mushrooms in DOG-1's immune support blend. It was selected for its PSK/PSP polysaccharide content and the available evidence supporting its role in canine immune health.
Scientific References
- Brown DC, Reetz J. Single agent polysaccharopeptide delays metastases and improves survival in naturally occurring hemangiosarcoma. Evid Based Complement Alternat Med. 2012;2012:384301. PMID: 22988473
- Wasser SP. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol. 2002;60(3):258-74. PMID: 12436306
- Guggenheim AG, Wright KM, Zwickey HL. Immune Modulation From Five Major Mushrooms: Application to Integrative Oncology. Integr Med (Encinitas). 2014;13(1):32-44. PMID: 26770080